CCM
AGIO icon

Cadence Capital Management’s Agios Pharmaceuticals AGIO Stock Holding History

Cadence Capital Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-10,635
Closed -$621K – 659
2017
Q1 		$621K Buy
+10,635
New +$510K 0.04% 467
2016
Q4 		– Sell
-13,290
Closed -$702K – 662
2016
Q3 		$702K Buy
+13,290
New +$579K 0.05% 408
2015
Q3 		– Sell
-28,580
Closed -$3.18M – 593
2015
Q2 		$3.18M Sell
28,580
-2,120
-7% -$228K 0.18% 148
2015
Q1 		$2.9M Sell
30,700
-8,320
-21% -$932K 0.18% 159
2014
Q4 		$4.37M Buy
39,020
+34,400
+745% +$3.07M 0.25% 112
2014
Q3 		$283K Buy
+4,620
New +$199K 0.01% 519

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return